FDA Inspection 1234060 — Shilpa Medicare Limited
The FDA completed an inspection of Shilpa Medicare Limited on Mar 1, 2024 in Hyderbad. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Mar 1, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Hyderbad (India)
Additional Details
Bioanalytical BA/BE